Rekha Dwivedi

Dec 4, 2023 | n.neurology.org | Kirandeep Kaur |Gautam Sharma |Rekha Dwivedi

MethodsThis was a prospective, 2-armed, assessor-blinded, parallel randomized controlled trial (RCT) with 3 assessment time points—baseline, 3 months, and 6 months (Figure 1, eFigure 1, links.lww.com/WNL/D201). The study was conducted in the neurology unit of All India Institute of Medical Sciences, New Delhi, India, from January 2018 to July 2020 (eAppendix 1).

Nov 8, 2023 | n.neurology.org | Kirandeep Kaur |Gautam Sharma |Rekha Dwivedi |Ashima Nehra

AbstractBackground and objectives: Persons with epilepsy are afflicted with co-morbidities such as stigma, anxiety and depression which have a significant impact on their quality of life. These co-morbidities remain largely unaddressed in resource limited countries.